Ubs Group Ag Pmv Pharmaceuticals, Inc. Transaction History

Ubs Group Ag

$527 Billion
Q4 2024

A detailed history of Ubs Group Ag transactions in Pmv Pharmaceuticals, Inc. stock. As of the latest transaction made, Ubs Group Ag holds 275,464 shares of PMVP stock, worth $388,404. This represents 0.0% of its overall portfolio holdings.

Number of Shares

275,464

Previous 178,866 54.01%

Holding current value

$388,404

Previous $266,000 56.02%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	BUY	$1.47 - $1.78 $141,999 - $171,944	96,598 Added 54.01%	275,464 $415,000
Q3 2024 Nov 14, 2024	BUY	$1.44 - $1.69 $135,306 - $158,797	93,963 Added 110.67%	178,866 $266,000
Q2 2024 Aug 13, 2024	SELL	$1.51 - $2.21 $73,568 - $107,673	-48,721 Reduced 36.46%	84,903 $137,000
Q1 2024 May 13, 2024	BUY	$1.51 - $3.12 $8,691 - $17,958	5,756 Added 4.5%	133,624 $227,000
Q4 2023 Feb 09, 2024	SELL	$1.23 - $6.6 $19,449 - $104,365	-15,813 Reduced 11.01%	127,868 $396,000
Q3 2023 Nov 09, 2023	BUY	$6.01 - $8.93 $276,231 - $410,440	45,962 Added 47.03%	143,681 $882,000
Q2 2023 Aug 11, 2023	BUY	$3.94 - $6.27 $31,815 - $50,630	8,075 Added 9.01%	97,719 $611,000
Q1 2023 May 12, 2023	SELL	$4.77 - $9.16 $928,928 - $1.78 Million	-194,744 Reduced 68.48%	89,644 $427,000
Q4 2022 Feb 08, 2023	BUY	$8.17 - $12.95 $1.34 Million - $2.13 Million	164,543 Added 137.3%	284,388 $2.47 Million
Q3 2022 Nov 10, 2022	SELL	$11.4 - $17.18 $2.63 Million - $3.96 Million	-230,465 Reduced 65.79%	119,845 $1.43 Million
Q2 2022 Aug 10, 2022	BUY	$9.23 - $22.43 $1.49 Million - $3.62 Million	161,299 Added 85.34%	350,310 $4.99 Million
Q1 2022 May 16, 2022	BUY	$14.86 - $23.55 $893,145 - $1.42 Million	60,104 Added 46.63%	189,011 $3.94 Million
Q4 2021 Feb 14, 2022	BUY	$19.99 - $30.24 $657,051 - $993,958	32,869 Added 34.22%	128,907 $2.98 Million
Q3 2021 Nov 15, 2021	BUY	$26.84 - $36.58 $2.55 Million - $3.47 Million	94,956 Added 8775.97%	96,038 $2.86 Million
Q2 2021 Aug 13, 2021	SELL	$28.01 - $36.01 $332,114 - $426,970	-11,857 Reduced 91.64%	1,082 $37,000
Q1 2021 May 12, 2021	BUY	$30.66 - $49.5 $319,262 - $515,443	10,413 Added 412.23%	12,939 $426,000
Q4 2020 Feb 11, 2021	BUY	$31.86 - $61.51 $62,286 - $120,252	1,955 Added 342.38%	2,526 $155,000
Q3 2020 Nov 12, 2020	BUY	$35.5 - $38.0 $20,270 - $21,698	571 New	571 $20,000

Others Institutions Holding PMVP

# of Institutions

Shares Held

41.8M

Call Options Held

500

Put Options Held

500

View Full List

About PMV Pharmaceuticals, Inc.

Ticker PMVP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,622,600
Market Cap $64.3M
Description
PMV Pharmaceuticals, Inc., a precision oncology company, engages in the discovery and development of small molecule and tumor-agnostic therapies for p53 mutations in cancer. The company's lead product candidate is PC14586, a small molecule that corrects a p53 protein containing the Y220C mutation and restores wild-type p53 function. It is also d...

More about PMVP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Account